Clenbuterol - Unit: 100 pills (40 mcg/pill)

Clenbuterol - Unit: 100 pills (40 mcg/pill)

REF-OS-BT-CLB1-100
In-stock
$59.00
No tax

Active Ingredient: Clenbuterol

Pack: 100 tabs (40mg/tab)

Manufacturer: Biotech

Half Life: 36-48 hours

Detection Time: 4-5 days

Anabolic Rating: N/A

Androgenic Rating: N/A

Dosage: male mg per 40-160 per day , female 40-100 mg per day.

Common brands: Meltos, Clen, Dilaterol, Spiropent, Ventipulmin, Clenbuterol, Clenbuterol Hydrochloride, Astralean, Clenbuterol-ver, Clenbutrol, Spiropent, Clenbu, ClenoX, Gtex, Clenbuterlene, Clenburetol, Clenbutaplex, KlenPrime, Clen-Max, Clen-UK, Hotbol, Claire, Monores, Brontel, Clenodex, Clenbulol

Clenbuterol is a prescribed Asthma medication which is catabolic to fatand anabolic to muscle. Clenbuterol's most valid application seems to be as a precontest,cutting drug.It isa Beta-2 adrenergic agonist.This means it acts just like adrenaline (epinephrine) at a certain type of receptor named Beta-2. Clenbuterol belongs to a broad group of drugs knows as sympethomlmet­ ics.These drugs affect that sympathetic nervous system in a wide number of ways,largely mediated by the distribution of adrenoceptors. There are actually nine different types of these receptors In the body, which are classified as either alpha or beta and further subcategorized by type number. Depending on the specific affinities of these agents for the various recep­ tors,they can potentially be used in the treatment of conditions such as asthma, hypertension, cardiovascular shock, arrhythmias, migraine headaches and anaphylactic shock. Consequently causing an enlargement of muscle cell : and obtain maximum strength and muscle mass Fat- burning effect.Mean burn fat without dieting ;it will be Increase body temperature 1• C (good effect) Hand shaking is normally happen (tremor)

CONTRAINDICATIONS: Individuals who have been diagnosed of cardiovascular problems should not take Clenbuterol.

DOSAGE AND DIRECTIONS FOR USE: Clenbuterol Hydrochloride tablets should be orally consumed. Adult dose:60-120 mg per day,divided throughout the day.2 days on,2 days off /2 weeks on 3 weeks off. Excessive use over the recommended dose of about 120-160 mg can cause muscle tremors, headache, dizziness, and gastric irritation. Persons self-administering the drug for weight loss or to improve athletic perfor­ mance have experienced nausea, vomiting, diaphoresis, palpitations, tachycardia,and myocardial infarction. Use of the drug may be confirmed by detecting its presence in semen or urine.

SIDE EFFECTS AND SPECIAL PRECAUTIONS: Nervousness, tremors of the hands, headaches, early onset asthma and insomnia. As long as the electrolyte status is maintained (esp. potassium} denbuteroldoes not cause too many problems. Muscle cramps are the most common. If you have a job that requires lots of manual dexterity then clenbuterolcan be more problematic.The tremor it gives in the hands can make steady fine movements virtually impossible. Fortunately, this effect often diminishes over a week or two of continued usage. Clenbuterol can have some serious side effects (like sudden death) at very high dosages. Clenbuterol works but it is hard on your system.Buy a good blood pressure monitor and use it several times a day. Base your dosage on your BP and resting pulse and your lack of side effects. Most of the actions ofcatecholamines and sympathomimetic agents can be classified into seven broad types:(1) peripheral excitatory action on certain types of smooth muscles such as those in blood vessels supplying the skin, kidney. and mucous membranes,and on the gland cells,such as those of the sallvary and sweat glands;(2) a peripheral inhibitory action on certain other types of smooth muscle,such as those in the wall of the gut, in the bronchialtree, and In blood vessels supplying skeletal muscle;(3) a cardiac excitatory action, responsible for in increase in heart rate and force of contraction;{4) metabolic actions,such as an increase in the rate of glycog­ enolysis In liver and muscle and liberation of free fatty acids from adipose tissue;(5) endocrine actions, suchas modulation of the secretion of insulin, rennin,and pituitary hormones;(6) CNS actions, such as respiratory stimula­ tion and,with some of the drugs,an increase in wakefulness and psycho­ motor activityanda reduction in appetite;and presynaptic actions that result in either inhibition or facilitation of the release of the neurotransmit­ ters such as suchas norepinephrine and acetylcholine."

WARNINGS:

LIVER CELL TUMORS ARE REPORTED.MOST OFTEN THESE TUMORS ARE BENIGN AND ANDROGEN DEPENDENT, BUT FATAL MALIGNANT TUMORS HAVE BEEN REPORTED. WITH DRAWAL OF DRUG OFTEN RESULTS IN REGRESSION OR CESSATION OF PROGRESSION OF THE TUMOR.HOWEVER,HEPATIC TUMORS ASSOCIATED WITH ANDROGENS OR ANABOLIC STEROIDS ARE MUCH MORE VASCULAR THAN OTliER HEPATIC TUMORS AND MAY BE SILENT UNTIL LIFE-TliREATENING INTRA-ABDOMINAL HEMORRHAGE DEVELOPS. PELIOSIS HEPATIS,A CONDITION ARE ALSO REPORTED IN WHICH LIVER AND SOMETIMES SPLENIC TISSUE IS REPLACED WITH BlOOD-FillED CYSTS, HAS BEEN REPORTED IN PATIENTS RECEVING ANDROGENIC ANABOLIC STEROIDTHERAPY.TliESE CYSTS ARE SOMETIMES PRESENT WITH MINIMAL HEPATIC DYSFUNCTIOBUT AT OTHER TIMES TliEY HAVE BEEN ASSOCIATED WITH LIVER FAILURE.THEY ARE OFTEN NOT RECOGNIZED UNTIL LIFE-THREATENING LIVER FAILURE OR INTRA-AB­ DOMINAL HEMORRHAGE DEVELOPS.WITHDRAWAL OF DRUG USUALLY RESULTS IN COMPLETE DI5APPERRANCE OF LESIONS. BLOOD LIPID CHANGES THAT ARE KNOWN TO BE ASSOCIATED WITH INCREASED RISK OF ATliEROSCLEROSIS ARE SEEN IN PATIENTS TREAT­ ED WITH ANDROGENS AND ANABOLIC STEROIDS. THESE CHANGES INCLUDE DECREASED HIGH-DENSITY LIPOPROTEIN AND SOMETIMES INCREASED LOW-DENSITY LIPOPROTEIN.THE CHANGES MAY BE VERY MARKED AND COULD HAVE A SERIOUS IMPACT ON THE RISK OF ATHER­ OSCLEROSIS AND CORONARY ARTERY DISEASE.

INDICATIONS:

The drug clenbuterol is specifically a selective beta-2 sympathomimetic, primarily affecting only one of the three subsets of beta-receptors. Of particular interest is the fact that this drug has little beta-1 stimulating activity. Since beta-1 receptors are closely tied to the cardiac effects of these agents,this allows denbuterol to reduce reversible airway obstruction (and effect of beta-2 stimulation) with much less cardiovascular side effects compared to nonselective beta agonists. Clinical studies with this drug show it is extremely effective as a bronchodilator, with a low level of user complaints and high patient compliance. Clenbuterol also exhibits an extremely long half-life in the body, which is measured to be approximately 34 hours. This makes steady blood levels easy to achieve, requiring only a single or twice daily dosing schedule at most. This of course makes it much easier for the patient to use, and may tie in to its high compliance rate.

Such a mix can be further used during a steroid cycle, eliciting a much harder look from the anabolics. These cutting agents can often greatly inhibit extra fat storage during the cycle, even when using strong aromatiz- ing androgens. A clenbuterol/thyroid mix is also common when using growth hormone, further enhancing the thermogenic and anabolic effect of this therapy.

PATIENT MONITORING: Laboratory tests Women with disseminated breast carcinoma should have frequent determination of urine and serum calcium levels during the course of androgen therapy (See WARNINGS). Because of the hepatotoxicity associated with the use of clenbuterol liver function tests should be obtained periodically. Periodic (every six months) X-ray examinations of bone age should be made during treatment of prepubertal males to determine the rate of bone maturation and the effects of androgen therapy on the epiphyseal centers. Hemoglobin and hematocrit levels (to detect polycythemia) should be checked periodically in patients receiving long term androgen administra- tion. Serum cholesterol may increase during androgen therapy. Drug/Laboratory test interferences Androgens may decrease levels of thyroxine-binding globulin, resulting in decreased total T4 serum levels and increased resin uptake of T3 and T4. Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. Lipid profile: Serum Cholesterol, HDL, LDL,TG.

HOW SUPPLIED:

Clenbuterol® 40 mcg is supplied in box of 100 white tablets. For shelf-life please refer to the imprint on the pack. Keep out of reach of children. Should be at controlled room temperatures 15-30°C (59-86°F) Protect from sun light This drug has not been shown to be safe and effective for the enhancement of athletic performance!

No reviews
Product added to wishlist
Product added to compare.